Literature DB >> 18237599

Impact of chronic obstructive pulmonary disease on long-term outcome of patients hospitalized for heart failure.

Dan Rusinaru1, Imen Saaidi, Stephanie Godard, Haïfa Mahjoub, Caroline Battle, Christophe Tribouilloy.   

Abstract

Chronic obstructive pulmonary disease (COPD) is a frequently neglected co-morbidity in patients with heart failure (HF). The aim of this study was to evaluate the prognostic impact of COPD in patients hospitalized for HF. Consecutive patients (n=799) admitted for a first episode of HF in all healthcare establishments of the Somme department (France) during 2000 were prospectively enrolled. Baseline characteristics and long-term prognosis were compared according to COPD status. COPD was diagnosed in 156 patients (19.5%). Compared with the no-COPD group, patients with COPD were predominantly men, more often smokers, and had lower discharge prescription rates of beta blockers (6% vs 27%, p<0.001). Five-year survival rate in patients with COPD was significantly lower than that of the no-COPD group (31% vs 42%, p=0.03). Compared with the expected survival of the age- and gender-matched general population, the 5-year survival rate in patients with COPD was dramatically lower (31% vs 71%). On multivariable analysis, COPD was a strong predictor of poorer outcome (hazard ratio 1.53, 95% confidence interval 1.21 to 1.94, p<0.001). COPD was an independent predictor of mortality in patients with preserved left ventricular ejection fraction and in patients with reduced ejection fraction. In conclusion, patients with HF and associated COPD have a poor prognosis with an impressive excess mortality compared to HF patients without COPD and the general population. Beta-blocker prescription rates remain deceptively low in this category of patients with HF.

Entities:  

Mesh:

Year:  2007        PMID: 18237599     DOI: 10.1016/j.amjcard.2007.08.046

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  24 in total

1.  The burden of chronic obstructive pulmonary disease in patients hospitalized with heart failure.

Authors:  Mitja Lainscak; Lea Majc Hodoscek; Hans-Dirk Düngen; Mathias Rauchhaus; Wolfram Doehner; Stefan D Anker; Stephan von Haehling
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

Review 2.  Comorbidity of heart failure and chronic obstructive pulmonary disease: more than coincidence.

Authors:  Gülmisal Güder; Frans H Rutten
Journal:  Curr Heart Fail Rep       Date:  2014-09

3.  COPD in heart failure: are there long-term implications following acute heart failure hospitalization?

Authors:  Lauren B Cooper; Robert J Mentz
Journal:  Chest       Date:  2015-03       Impact factor: 9.410

4.  Change in comorbidity prevalence with advancing age among persons with heart failure.

Authors:  Sangeeta C Ahluwalia; Cary P Gross; Sarwat I Chaudhry; Linda Leo-Summers; Peter H Van Ness; Terri R Fried
Journal:  J Gen Intern Med       Date:  2011-05-15       Impact factor: 5.128

Review 5.  Epidemiology and clinical course of heart failure with preserved ejection fraction.

Authors:  Carolyn S P Lam; Erwan Donal; Elisabeth Kraigher-Krainer; Ramachandran S Vasan
Journal:  Eur J Heart Fail       Date:  2010-08-03       Impact factor: 15.534

6.  Comparison between ATS/ERS age- and gender-adjusted criteria and GOLD criteria for the detection of irreversible airway obstruction in chronic heart failure.

Authors:  Richard Steinacher; John T Parissis; Bernhard Strohmer; Jörg Eichinger; Dennis Rottlaender; Uta C Hoppe; Johann Altenberger
Journal:  Clin Res Cardiol       Date:  2012-03-07       Impact factor: 5.460

7.  Impact of COPD on the mortality and treatment of patients hospitalized with acute decompensated heart failure: the Worcester Heart Failure Study.

Authors:  Kimberly A Fisher; Mihaela S Stefan; Chad Darling; Darleen Lessard; Robert J Goldberg
Journal:  Chest       Date:  2015-03       Impact factor: 9.410

8.  Treatment Effectiveness in Heart Failure with Comorbidity: Lung Disease and Kidney Disease.

Authors:  Jerry H Gurwitz; David J Magid; David H Smith; Grace H Tabada; Sue Hee Sung; Larry A Allen; David D McManus; Robert J Goldberg; Mayra Tisminetzky; Alan S Go
Journal:  J Am Geriatr Soc       Date:  2017-09-05       Impact factor: 5.562

Review 9.  Challenges in the Management of Patients with Chronic Obstructive Pulmonary Disease and Heart Failure With Reduced Ejection Fraction.

Authors:  Abhishek Jaiswal; Astha Chichra; Vinh Q Nguyen; Taraka V Gadiraju; Thierry H Le Jemtel
Journal:  Curr Heart Fail Rep       Date:  2016-02

10.  Differences in clinical characteristics, management and short-term outcome between acute heart failure patients chronic obstructive pulmonary disease and those without this co-morbidity.

Authors:  John T Parissis; Chiara Andreoli; Nikolaos Kadoglou; Ignatios Ikonomidis; Dimitrios Farmakis; Ioanna Dimopoulou; Efstathios Iliodromitis; Maria Anastasiou-Nana; Mitja Lainscak; Giussepe Ambrosio; Alexandre Mebazaa; Gerasimos Filippatos; Ferenc Follath
Journal:  Clin Res Cardiol       Date:  2014-04-10       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.